CF Foundation unit backs Pulmatrix program in $1.4M deal; Neuralstem raises $7M;

Conversations on Twitter :

 @FierceBiotech: Neural stem cells partially restore mobility in paralyzed rats. Story | Follow @FierceBiotech

 @RyanMFierce: My conversation with biotech heavy hitter and NEA partner David Mott about investing big in therapeutics startups. Editor's Corner | Follow @RyanMFierce

> An affiliate of the Cystic Fibrosis Foundation has inked a $1.4 million deal with Lexington, MA-based biotech Pulmatrix to fund development of an inhaled drug dubbed PUR118 for treating patients with cystic fibrosis. Release

> Neuralstem ($CUR), a developer of stem cell therapies, has raised $7 million in a direct offering of common stock. Release

> Proteonomix has made a deal with the University of Medicine and Dentristry of New Jersey to execute a Phase I study of the company's candidate UMK-121 for patients with end-stage liver disease. Item

Pharma News

 @FiercePharma: Bayer picks up Teva's animal health biz for $145M. News | Follow @FiercePharma

 @EricPFierce: Health Canada says it will rank drug manufacturing issues by risk of product and by 3 levels of concern. FiercePharmaManufacturing article | Follow @EricPFierce

> U.S. consumers buy more, pay more for drugs. Article

> Mylan may make another acquisition in India. More

> Boehringer Ingelheim lets Facebook game loose. Story

Medical Device News

 @FierceMedDev: Tandem Diabetes Care raked in $36M to further market its super-slim insulin pump. News | Follow @FierceMedDev

 @MarkHFierce: Covidien expects medical device sales to grow 4% to 7% in FY 2013. Release | Follow @MarkHFierce

 @DamianFierce: U.K. engineers have come up with an ultrasound scanner that can made for about $65, targeting developing countries. More | Follow @DamianFierce

> Study: Second life possible for pacemaker harvested from autopsy. Story

> Dx company Response Genetics draws huge GSK investment. Item

And Finally… Amid a NASA rover's mission on Mars, a report questions whether Americans could eventually serve as life on the planet. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.